Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 19/7/2019
SIETES contiene 92793 citas

 1 a 20 de 107 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Ginkgo biloba: to be avoided due to severe adverse effects. Prescrire Int 2019;28:155-6. [Ref.ID 103129]
2. Cita con resumen
Herr M, Sirven N, Grondin H, Pichetti S, Sermet C. Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population. Eur J Clin Pharmacol 2017;73:1165-72. [Ref.ID 102024]
3.Tiene citas relacionadas Cita con resumen
Lee SWH, Lai NM, Chaiyakunapruk N, Chong DWK. Adverse effects of herbal or dietary supplements in G6PD deficiency: a systematic review. Br J Clin Pharmacol 2017;83:172-9. [Ref.ID 101929]
4. Cita con resumen
Chinthapalli K. The billion dollar business of being smart. BMJ 2015;351:h4829. [Ref.ID 99542]
5. Cita con resumen
Anónimo. Ginkgo biloba: diminution d'efficacité de l'éfavirenz. Prescrire 2014;34:749. [Ref.ID 98264]
6. Cita con resumen
Newmaster SG, Grguric M, Shanmughanandhan D, Ramalingam S, Ragupathy S. DNA barcoding detects contamination and substitution in North American herbal products. BMC Med 2013;11:222. [Ref.ID 96274]
7. Cita con resumen
Briggs JP, Killen J. Perspectives on complementary and alternative medicine research. JAMA 2013;310:691-2. [Ref.ID 95950]
8.Enlace a cita original
Posadzki P, Watson L, Ernst E. Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews. Eur J Clin Pharmacol 2013;69:295-307. [Ref.ID 95150]
9.Enlace a cita original Cita con resumen
Posadzki P, Watson L, Ernst E. Herb-drug interactions: an overview of systematic reviews. Br J Clin Pharmacol 2013;75:603-18. [Ref.ID 95037]
10. Cita con resumen
Anónimo. Tinnitus. Drug Ther Bull 2013;51:20-4. [Ref.ID 94861]
11. Cita con resumen
Skalli S, Bencheikh RS. Safety monitoring of herb-drug interactions: a component of pharmacovigilance. Drug Saf 2012;35:785-91. [Ref.ID 93810]
13.Enlace a cita original
Tsai HH, Lin HW, Pickard SA, Tsai HY, Mahady GB. Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review. International Journal of Clinical Practice 2012;66:1056-78. [Ref.ID 93669]
14. Cita con resumen
Vellas B, Coley N, Ousset PJ, Berrut G, Dartigues J-F, Dubois B, Grandjean H, Pasquier F, Piette F, Robert P, Touchon J, Garnier P, Mathiex-Fortunet H, Andrieu S, for the GidAge Study Group. Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol 2012;11:851-9. [Ref.ID 92936]
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet 2011;377:1019-31. [Ref.ID 90421]
16. Cita con resumen
Vitalone A, Menniti-Ippolito F, Moro PA, Firenzuoli F, Raschetti R, Mazzanti G. Suspected adverse reactions associated with herbal products used for weight loss: a case series reported to the Italian National Institute of Health. Eur J Clin Pharmacol 2011;67:215-24. [Ref.ID 90094]
17. Cita con resumen
Snitz BE, O'Meara ES, Carlson MC, Arnold AM, Ives DG, Rapp SR, Saxton J, López OL, Dunn LO, Sink KM, DeKosky ST, for the Ginkgo Evaluation of Memory (GEM) Study Investigators. Ginkgo biloba for prevention cognitive decline in older adults. A randomized trial. JAMA 2009;302:2663-70. [Ref.ID 87397]
18.Enlace a cita original
Jacobsson I, Jönsson AK, Gerdén B, Hägg S. Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden. Pharmacoepidemiol Drug Saf 2009;18:1039-47. [Ref.ID 87050]
19.Enlace a cita original
Bosch M, Bonafont X. Efecte de l'ús de plantes medicinals en el període perioperatori. Butlletí d'Informació Terapèutica 2009;21:19-24. [Ref.ID 86922]
Tang JL, Liu B-Y, Ma KW. Traditional Chinese medicine. Lancet 2008;372:1938-40. [Ref.ID 84661]
Seleccionar todas
 1 a 20 de 107 siguiente >>